lic deals provide revenue there may not need to be raises in the future and James said that in an interview the last one or two ago - there ‘may not’ need to be another cap raise.
when Paxalisib partners it would provide enough capital to fund a couple more compound choices for the pipeline...
the RPDD alone would sell for over 100 million aud - up
to 350 million USD
